Stay updated on Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Sign up to get notified when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.

Latest updates to the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page
- Check4 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, signaling a newer version of the page. This change appears to be a metadata update rather than a substantive modification to study details or layout.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the study record. This change reflects a version bump rather than a substantive modification to content or data.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3, reflecting a new release or patch applied to the site. This indicates a software update rather than a substantive content change.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a backend/content management update rather than a substantive change to the study details.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and introduces explicit Last Verified and Last Known Status Was fields, along with a new Revision: v3.6.0 label. Older labels such as Verified and Last known status was:, and Intervention / Treatment are removed or reformatted; Intervention / Treatment is replaced by Intervention/Treatment, with the page revision updating from v3.5.5 to v3.6.0.SummaryDifference1%

- Check68 days agoChange DetectedThe revision label updated from v3.5.4 to v3.5.5, signaling a page version bump tied to an update of the build or metadata rather than substantive study content.SummaryDifference0.1%

Stay in the know with updates to Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Immune Response of eOD-GT8 & g28v2 mRNA-1644 Clinical Trial page.